Larvol Delta - Pzer-Inc-PFE-has-launched-VESPERJM-a-Phase-3-study-in-Japan-that-tests-oncemonthly-berobenatide-in-adults-with-obesity-including-some-with-type-2-diabetes

berobenatide (PF-08653944) - Pfizer

https://www.tipranks.com/news/company-announcements/pfizers-next-move-in-obesity-drugs-what-the-new-vesper-jm-trial-means-for-pfe-investors

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next